Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Cash from Financing Activities (2019 - 2025)

Historic Cash from Financing Activities for Korro Bio (KRRO) over the last 7 years, with Q3 2025 value amounting to $128000.0.

  • Korro Bio's Cash from Financing Activities fell 8241.76% to $128000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 9941.93%. This contributed to the annual value of $69.4 million for FY2024, which is 6306.21% down from last year.
  • Korro Bio's Cash from Financing Activities amounted to $128000.0 in Q3 2025, which was down 8241.76% from $5000.0 recorded in Q2 2025.
  • Over the past 5 years, Korro Bio's Cash from Financing Activities peaked at $144.6 million during Q4 2023, and registered a low of -$2.2 million during Q3 2023.
  • In the last 5 years, Korro Bio's Cash from Financing Activities had a median value of $186000.0 in 2022 and averaged $14.4 million.
  • Per our database at Business Quant, Korro Bio's Cash from Financing Activities plummeted by 401428.57% in 2023 and then skyrocketed by 18775555.56% in 2024.
  • Quarter analysis of 5 years shows Korro Bio's Cash from Financing Activities stood at $109000.0 in 2021, then plummeted by 318.35% to -$238000.0 in 2022, then surged by 60851.26% to $144.6 million in 2023, then crashed by 99.36% to $932000.0 in 2024, then plummeted by 86.27% to $128000.0 in 2025.
  • Its Cash from Financing Activities was $128000.0 in Q3 2025, compared to $5000.0 in Q2 2025 and $172000.0 in Q1 2025.